Literature DB >> 18680128

Controllable cyclization reactions of 2-(2',3'-allenyl)acetylacetates catalyzed by gold and palladium affording substituted cyclopentene and 4,5-dihydrofuran derivatives with distinct selectivity.

Xuefeng Jiang1, Xiaojing Ma, Zilong Zheng, Shengming Ma.   

Abstract

Efficient room-temperature syntheses of cyclopentenes and 4,5-dihydrofurans with different substitution patterns were performed starting from the same materials (i.e., 2-(2',3'-allenyl)acetylacetates). Depending on the choice of metal catalyst, the Au-catalyzed reaction afforded C-attack-5-endo cyclization products 2, whereas the Pd-catalyzed one led to the formation of O-attack-5-exo cyclization products 3. The selectivity may be explained by the steric and electronic effects of the substrates and catalysts.

Entities:  

Year:  2008        PMID: 18680128     DOI: 10.1002/chem.200800793

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  Diastereoselective Au-Catalyzed Allene Cycloisomerizations to Highly Substituted Cyclopentenes.

Authors:  Ryan D Reeves; Alicia M Phelps; William A T Raimbach; Jennifer M Schomaker
Journal:  Org Lett       Date:  2017-06-09       Impact factor: 6.005

2.  Scope and mechanistic investigations of Pd-catalyzed coupling/cyclizations and cycloisomerizations of allenyl malonates.

Authors:  Logan E Vine; Ryan D Reeves; Eleanor M Landwehr; Israel Fernández; Jennifer M Schomaker
Journal:  ACS Catal       Date:  2021-07-15       Impact factor: 13.700

3.  Stereodivergent Metal-Catalyzed Allene Cycloisomerizations.

Authors:  Ryan D Reeves; Caitlin N Kinkema; Eleanor M Landwehr; Logan E Vine; Jennifer M Schomaker
Journal:  Synlett       Date:  2020-02-04       Impact factor: 2.454

4.  Tandem Pd-Catalyzed Cyclization/Coupling of Non-Terminal Acetylenic Activated Methylenes with (Hetero)Aryl Bromides.

Authors:  Aleksandra Błocka; Wojciech Chaładaj
Journal:  Molecules       Date:  2022-01-19       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.